1. Silk fibroin/polyvinyl alcohol composite film loaded with antibacterial AgNP/polydopamine-modified montmorillonite; characterization and antibacterial properties.
- Author
-
Sun X, Liang H, Wang H, Meng N, Jin S, and Zhou N
- Subjects
- Animals, Mice, Microbial Sensitivity Tests, Cell Line, Spectroscopy, Fourier Transform Infrared, Polyvinyl Alcohol chemistry, Bentonite chemistry, Anti-Bacterial Agents pharmacology, Anti-Bacterial Agents chemistry, Polymers chemistry, Nanocomposites chemistry, Fibroins chemistry, Escherichia coli drug effects, Staphylococcus aureus drug effects, Indoles chemistry, Indoles pharmacology
- Abstract
In this study, a kind of nanocomposite film was fabricated via combining silk fibroin, polyvinyl alcohol (SF/PVA) and AgNP/polydopamine-modified Montmorillonite (AgNP/PDA-Mt). The structural characteristics and properties of the SF/PVA/AgNP/PDA-Mt nanocomposites films were identified using X-ray diffraction (XRD), Thermal gravimetric analyzer (TGA), Fourier transform infrared spectroscopy (FTIR), EDS-mapping analyses and Scanning electron microscope (SEM). The results indicated enhanced thermal performance of SF/PVA/AgNP/PDA-Mt nanocomposites with increased AgNP/PDA-Mt weight. The nanocomposite film exhibited excellent antibacterial activity against E. coli and S. aureus. The 2 % SF/PVA/AgNP/PDA-Mt film showed the highest zone of inhibition with an average inhibition circle diameter of 26.1 mm against E. coli and 20.61 mm against S. aureus. Cytotoxicity test results indicated that the nanocomposites films were biocompatible with L929 cells with a 100 % survival rate, which can be considered as one of the advantages of new nanocomposites films. These findings suggest that SF/PVA/AgNP/PDA-Mt films have potential clinical applications in wound dressing and antibacterial biomedical applications., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023. Published by Elsevier B.V.)
- Published
- 2023
- Full Text
- View/download PDF